FDA clears Welch Allyn Protocol's wireless patient monitor:
This article was originally published in Clinica
Welch Allyn Protocol has received US FDA 510(k) clearance to market its Micropaq wireless ambulatory patient monitor. The device, developed principally for cardiac care, monitors ECG, heart rate and pulse oximetry. It is compact and wearable, weighing under a pound. The product can be connected wirelessly to the Beaverton, Oregon company's Acuity central workstation and its FlexNet network, which provide vital signs data and patient information between any locations via secure internet access. The device can also be used in applications outside cardiac care because it provides an LCD of vital sign data and can operate outside of the wireless network.